Cargando…
Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with COVID-19: A Single Center Experience
Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) patients particularly presenting as rapidly progressive glomerulonephritis (RPGN) are at extremely high risk of progressing to end-stage kidney disease (ESKD); therefore, timely intervention is important. We describe our experien...
Autores principales: | Latief, Muzamil, Mir, Tajamul H., Wani, Mohd L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185014/ https://www.ncbi.nlm.nih.gov/pubmed/37197050 http://dx.doi.org/10.4103/ijn.ijn_423_21 |
Ejemplares similares
-
Bullous hemorrhagic Sweet syndrome with cryptococcoid neutrophils in patients positive for antineutrophil cytoplasmic antibody without primary vasculitis
por: Sherban, Alex, et al.
Publicado: (2020) -
Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Geetha, Duvuru, et al.
Publicado: (2018) -
Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
por: Felzer, Jamie R., et al.
Publicado: (2021) -
Caveolin-1 Single Nucleotide Polymorphism in Antineutrophil Cytoplasmic Antibody Associated Vasculitis
por: Chand, Sourabh, et al.
Publicado: (2013) -
Antineutrophilic Cytoplasmic Antibody Positive Vasculitis
Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015)